These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 15233671)

  • 1. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease.
    Adams LA; Lindor KD; Angulo P
    Am J Gastroenterol; 2004 Jul; 99(7):1316-20. PubMed ID: 15233671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease].
    Cho DH; Choi MS; Kim DH; Kim DY; Shim SG; Lee JH; Koh KC; Paik SW; Yoo BC; Rhee JC
    Korean J Hepatol; 2005 Sep; 11(3):261-7. PubMed ID: 16177552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?
    Yatsuji S; Hashimoto E; Kaneda H; Taniai M; Tokushige K; Shiratori K
    J Gastroenterol; 2005 Dec; 40(12):1130-8. PubMed ID: 16378177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
    Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
    Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
    Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune hepatitis in children: what is different from adult AIH?
    Mieli-Vergani G; Vergani D
    Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of the prevalence and clinical significance of positive autoantibodies after pediatric liver transplantation.
    Avitzur Y; Ngan BY; Lao M; Fecteau A; Ng VL
    J Pediatr Gastroenterol Nutr; 2007 Aug; 45(2):222-7. PubMed ID: 17667719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis.
    Granito A; Muratori L; Muratori P; Pappas G; Guidi M; Cassani F; Volta U; Ferri A; Lenzi M; Bianchi FB
    J Clin Pathol; 2006 Mar; 59(3):280-4. PubMed ID: 16505279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies and their antigens in autoimmune hepatitis.
    Bogdanos DP; Mieli-Vergani G; Vergani D
    Semin Liver Dis; 2009 Aug; 29(3):241-53. PubMed ID: 19675997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis.
    Mehendiratta V; Mitroo P; Bombonati A; Navarro VJ; Rossi S; Rubin R; Herrine SK
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):98-103. PubMed ID: 18955163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
    Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
    Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease.
    Loria P; Carulli N; Lonardo A
    Am J Gastroenterol; 2005 May; 100(5):1200-1; author reply 1201-2. PubMed ID: 15842599
    [No Abstract]   [Full Text] [Related]  

  • 16. [Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations].
    Montes Santiago J; Gambón Deza F; García García MJ; González Vázquez L; Hermo Brión JA; Pérez Alvarez R
    An Med Interna; 2000 Jul; 17(7):343-6. PubMed ID: 10981329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis.
    Nezu S; Tanaka A; Yasui H; Imamura M; Nakajima H; Ishida H; Takahashi S
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1448-54. PubMed ID: 16911691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of selected serologic markers in the diagnosis of autoimmune hepatitis].
    Marcinkiewicz M; Gryc E; Kreczko S
    Przegl Lek; 1998; 55(11):614-8. PubMed ID: 10216378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of autoimmunity in nonviral chronic liver disease.
    Amarapurkar DN; Amarapurkar AD
    J Assoc Physicians India; 2000 Nov; 48(11):1064-9. PubMed ID: 11310382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
    Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
    Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.